Navigation Links
One-year results from Horizons-AMI trial reported at TCT 2009
Date:9/21/2009

SAN FRANCISCO, CA SEPTEMBER 21, 2009 Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.

Two teams of European researchers will report on one-year results from these two substudies at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). Both will be presented as poster abstracts (TCT-306 and TCT-304) on Tuesday, September 22 between 8:00 a.m. and 10:00 a.m. in Hall D of The Moscone Center.

The landmark HORIZONS-AMI trial, sponsored by CRF, is expected to significantly impact the way that patients are treated. Two-year data from the trial will also be presented as a Late Breaking Trial on Friday, September 25 at TCT.

The two abstracts examine additional important information regarding outcomes of patients with acute myocardial infarction (AMI). One of the substudies focuses on primary angioplasty in acute anterior myocardial infarction with bivalirudin compared to unfractionated heparin plus GpIIb/IIIa inhibitors. This includes patients with massive heart attacks and the effect of pharmacotherapy in these patients. The other substudy examines the benefits of bivalirudin therapy in the highest risk patients who present with a heart attack.

A research team lead by Jochen Whrle, MD, University of Ulm (Ulm, Germany) looked at clinical outcomes in patients with ST segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) of left anterior descending (LAD) coronary artery disease compared to non-LAD lesions. Investigators evaluate
'/>"/>

Contact: Judy Romero
jromero@crf.org
347-407-2774
Cardiovascular Research Foundation
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. 132 Members of Congress Urge One-Year Delay in Controversial Medicare Bidding Program for Home Medical Equipment
2. INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
3. New type of sirolimus-eluting stent demonstrates superior results
4. Details Emerge About Approach, Results of First US Face Transplant
5. Instrumentation Laboratory Announces Passion & Results Award Winners
6. Bioniche Reports Fiscal 2009 Year-End Results
7. Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania
8. Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results
9. PRO-DEX, INC. Announces Fiscal 2009 Fourth Quarter and Full-year Results
10. Immucor to Announce Fiscal First Quarter Financial Results on Thursday, October 1, 2009
11. Neogen Corporation Announces 1st Quarter Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... a few extra cups of coffee each month might ... known as primary sclerosing cholangitis (PSC), a new study ... Minn., found that drinking coffee was associated with a ... to cirrhosis of the liver, liver failure and biliary ... relationship. "While rare, PSC has extremely detrimental ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) There are ... procedures commonly used to diagnose or treat gastrointestinal ... Week (DDW). , A study by New ... that more objective testing may substantially reduce the ... (GERD). Although GERD is believed to affect nearly ...
(Date:5/18/2013)... May 18, 2013 Assisted living ... comes to safety and comfort of their residents. ... provides clients with an effective and cost-efficient solution ... is an integrated, turnkey communications solution that helps ... allowing residents independence and privacy. , The ...
(Date:5/18/2013)... 18, 2013 Transvaginal mesh lawsuits ... to move forward in a consolidated litigation underway in ... reports. According to a notice on the Court’s website, ... mesh litigation will be held on Wednesday, May 22nd. ... filed in the proceeding on behalf of women who ...
(Date:5/18/2013)... “World Healthcare IT Market: Trends & Forecast (2010 – ... and opportunities in North America, Europe, Asia, & Rest ... 89 market data tables , 20 ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers will ... IT market is expected to grow from $99.6 billion ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3
... ALAMITOS, Calif., July 7 Traditional medicine,attempts to treat ... underlying causes. As a result, menopausal women may have ... Solutions, a,woman may significantly decrease her menopausal symptoms using ... healing is to remove or reduce all of the ...
... housekeeping enzyme has been found to play a major ... can nurture hematopoietic,stem cells, MEMPHIS, Tenn., July 7 ... as a run-of-the-mill enzyme that helps to,recycle molecules in ... according to St. Jude Children,s Research Hospital investigators., ...
... Children as young as 2 should be tested for high ... In a further concession to the impact of the childhood ... pediatricians is recommending that kids as young as 8 years ... problems later in life. , The American Academy of Pediatrics ...
... July 7 Joel Madden, lead vocalist,for the ... UNICEF,s newest Goodwill Ambassador, officials with the U.S.,Fund ... Sunday during a cable broadcast on global child ... Time, which aired on CNN and,was hosted by ...
... NEW YORK, July 7 Many people ... complication associated with diabetes -- serious gum,disease. ... health and diabetes., Listen to ... Registered journalists can access video, audio, ...
... July 7 iCAD, Inc. (Nasdaq:,ICAD), an industry-leading ... identification of cancer, today announced that the,Company,s second ... open on Thursday, July 31, 2008. iCAD management ... for 10:00 a.m. ET that same,morning., Shareholders ...
Cached Medicine News:Health News:Holistic Health Solutions Offers a Long Awaited Relief for Menopausal Symptoms 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 3Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 4Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 3Health News:Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 2Health News:iCAD to Host Second Quarter 2008 Financial Results Conference Call on Thursday, July 31, 2008 2Health News:iCAD to Host Second Quarter 2008 Financial Results Conference Call on Thursday, July 31, 2008 3
(Date:5/17/2013)...  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... UBS Global Healthcare Conference in New York ... at 11 a.m. Eastern Time. To listen to the ... the Investor Relations section of the Company,s Web site at ... days after the event. About Orexigen® Therapeutics ...
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- United Medical Education, a ... Support (ACLS), Pediatric Advanced Life Support (PALS) and Basic ... and ACLS online course manuals. In order ... need to build an account with the company. By ... programs, United Medical Education is setting a precedent among ...
(Date:5/17/2013)... , Puerto Rico , May 17, ... central and western Puerto Rico , Caribbean ... PR) Center has improved its radiation therapy capabilities with the ... Puerto Rico . Versa HD offers clinicians ... range of tumors throughout the body, while also enabling treatment ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... Oct. 7 Today the Roskamp Institute said that it ... trials of RCP-006, a compound found in tobacco, for the ... Creek Pharmaceuticals, a subsidiary of Star Scientific in Virginia, and ... In laboratory tests with cells, the compound, ...
... NEW YORK, Oct. 7 Pfizer Oncology will ... approaches to researching treatments for patients with rare ... at the 35 th European Society for ... October 8-12.   (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Roskamp Institute to Begin Human Alzheimer's Clinical Trials With a Natural Compound in Tobacco 2Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 2Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 3Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 4Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 5Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 6Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 7Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 8Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 9Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 10Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 11Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets 12
The Nordt Knot Tightener allows both pushing and spreading of knots, reproducing identical techniques,used when tying traditional open knots. The Nordt Knot Tightener allows tying of any type of s...
... RC Retractor comes with several ... superficial or deep muscle retraction. ... retraction in three different directions: ... The fiber optic light cable ...
Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
Soft tissue shoulder retractor system...
Medicine Products: